"Designing Growth Strategies is in our DNA"

Influenza Medication Market Size, Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI101843

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview of Influenza Epidemiology
    2. Analysis of Disease Burden of Influenza, By Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Analysis of the Impact of the Launch of Generics on the Influenza Medication Market
    6. Key Industry Developments
  5. Global Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis, Insights and Forecast – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Genentech, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Shionogi & Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Seqirus (CSL)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. BIOCRYST PHARMACEUTICALS, INC.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. GlaxoSmithKline plc
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Lupin Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Zydus Pharmaceuticals, Inc. (Zydus Cadila)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Amneal Pharmaceuticals LLC
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Macleods Pharmaceuticals Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      11. Alvogen
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      12. Others
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
  12. Strategic Recommendations

List of Figures:

Figure 1:  Global Influenza Medication Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Influenza Medication Market Value Share (%), by Treatment, 2018 & 2026

Figure 3:  Global Influenza Medication Market Forecast (US$ Mn), by Baloxavir marboxil, 2015-2026

Figure 4:  Global Influenza Medication Market Forecast (US$ Mn), by Oseltamivir phosphate, 2015-2026

Figure 5:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 6:  Global Influenza Medication Market Value Share (%), by Influenza Type, 2018 & 2026

Figure 7:  Global Influenza Medication Market Forecast (US$ Mn), by Influenza A, 2015-2026

Figure 8:  Global Influenza Medication Market Forecast (US$ Mn), by Influenza B, 2015-2026

Figure 9:  Global Influenza Medication Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 10:  Global Influenza Medication Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 11:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 12:  Global Influenza Medication Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 13:  Global Influenza Medication Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 14:  Global Influenza Medication Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 15:  Global Influenza Medication Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 16:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 17:  Global Influenza Medication Market Value (US$ Mn), by Region, 2018 & 2026

Figure 18:  North America Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 19:  North America Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 20:  North America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 21:  North America Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 22:  North America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 23:  North America Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 24:  North America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 25:  North America Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 26:  North America Influenza Medication Market Value (US$ Mn), By Country, 2018 & 2026

Figure 27:  North America Influenza Medication Market Value Share (%), By Country, 2018

Figure 28:  Europe Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 29:  Europe Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 30:  Europe Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 31:  Europe Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 32:  Europe Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 33:  Europe Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 34:  Europe Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 35:  Europe Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 36:  Europe Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 37:  Europe Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 38:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 39:  Asia Pacific Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 40:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 41:  Asia Pacific Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 42:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 43:  Asia Pacific Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 44:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 45:  Asia Pacific Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 46:  Asia Pacific Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 47:  Asia Pacific Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 48:  Latin America Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 49:  Latin America Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 50:  Latin America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 51:  Latin America Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 52:  Latin America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 53:  Latin America Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 54:  Latin America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 55:  Latin America Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 56:  Latin America Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 57:  Latin America Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 58:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 59:  Middle East & Africa Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 60:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 61:  Middle East & Africa Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 62:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 63:  Middle East & Africa Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 64:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 65:  Middle East & Africa Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 66:  Middle East & Africa Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 67:  Middle East & Africa Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 68:  Global Influenza Medication Market Share (%), By Company, 2018

List of Tables:

Table 1:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 2:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015–2026

Table 3:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 4:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 5:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 6:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 7:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 8:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 9:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 10:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 11:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 12:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 13:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 14:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 15:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 17:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 18:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 22:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 23:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 24:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 25:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 26:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 27:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 28:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 29:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 30:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 class=
  • Feb, 2020
  • 2018
  • 2015-2017
  • 145

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X